Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
Cancers|April 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal AdenocarcinomasNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Gut|June 5, 2024
Protective function of sclerosing cholangitis on IBDTanja Bedke, Friederike Stumme, Miriam Tomczak, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 2, 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian CancerSören Weidemann, Natalia Gorbokon, Maximilian Lennartz, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
World Journal of Urology|May 4, 2020
A non-diploid DNA status is linked to poor prognosis in renal cell cancerFranziska Büscheck, Christoph Fraune, Martina Kluth, et al.
Cancers|April 14, 2025
Deficiency of MTAP Is Frequent and Mostly Homogeneous in Pancreatic Ductal AdenocarcinomasNatalia Gorbokon, Katharina Teljuk, Viktor Reiswich, et al.
Gut|June 5, 2024
Protective function of sclerosing cholangitis on IBDTanja Bedke, Friederike Stumme, Miriam Tomczak, et al.
Virchows Archiv : an International Journal of Pathology|August 6, 2024
PAX8 expression in cancerous and non-neoplastic tissue: a tissue microarray study on more than 17,000 tumors from 149 different tumor entitiesNatalia Gorbokon, Sarah Baltruschat, Maximilian Lennartz, et al.
Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.
Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.
Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
Virchows Archiv : an International Journal of Pathology|August 11, 2022
FABP1 expression in human tumors: a tissue microarray study on 17,071 tumorsDavid Dum, Ana Ocokoljic, Maximilian Lennartz, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 2, 2023
High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian CancerSören Weidemann, Natalia Gorbokon, Maximilian Lennartz, et al.
Pageof 12